NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-06-30 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 0.00% 10-Q · filed 2026-05-15 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-04-15 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-09 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-05 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 0.00% 10-K · filed 2024-03-05 | |||
| 2020-12-31 | 0.00% 10-K · filed 2023-02-28 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-20 | |||
| 2012-12-31 | 0.00% 10-K · filed 2014-04-01 | |||
| 2011-12-31 | 0.00% 10-K · filed 2013-04-08 |